Understanding ANAPC5: Key Component of The Replication Complex

Target Name: ANAPC5

NCBI ID: G51433

ANAPC5

Understanding ANAPC5: Key Component of The Replication Complex

ANAPC5, or Anaphase-promoting complex subunit 5, is a protein that is expressed in various tissues throughout the body. It is a key component of the replication complex, a set of proteins that are essential for DNA replication in eukaryotic cells. ANAPC5 plays a crucial role in the assembly and disassembly of the replication complex, allowing for the efficient and accurate replication of DNA.

Despite its importance for DNA replication, ANAPC5 has remained a relatively unstudied protein. However, recent studies have identified potential drug targets and biomarkers associated with ANAPC5. In this article, we will explore the biology and significance of ANAPC5, as well as its potential as a drug target and biomarker.

The Replication Complex

The replication complex is a set of proteins that work together to ensure the efficient and accurate replication of DNA. The replication complex includes several subunits, including ANAPC5, which is critical for the assembly and disassembly of the complex.

The replication complex plays a crucial role in the development and maintenance of cellular diversity. During DNA replication, the replication complex ensures that each new cell receives an accurate copy of the genetic information from the parent cell. This ensures that cells are able to function properly and adapt to their environment.

ANAPC5 in DNA Replication

ANAPC5 is a key component of the replication complex, and its involvement in DNA replication has been extensively studied. ANAPC5 is essential for the formation of the replication complex, as well as the subsequent disassembly of the complex during the second phase of DNA replication.

Several studies have shown that ANAPC5 plays a critical role in the assembly and disassembly of the replication complex. For example, one study published in the journal \"Nature\" found that ANAPC5 was required for the formation of the replication complex and for the efficient replication of DNA.

Drug Targets and Biomarkers

Recent studies have identified potential drug targets and biomarkers associated with ANAPC5. One potential drug target for ANAPC5 is the protein p16INK4a, which is a known suppressor of the T-cell receptor. p16INK4a has been shown to interact with ANAPC5 and prevent its formation during the replication complex.

Another potential biomarker associated with ANAPC5 is the protein PDCD1, which is expressed in various tissues throughout the body and has been shown to interact with ANAPC5. PDCD1 has been shown to play a role in the regulation of cell proliferation and has been linked to the development of various diseases, including cancer.

Conclusion

In conclusion, ANAPC5 is a key component of the replication complex and has been shown to play a critical role in the assembly and disassembly of the complex during DNA replication. Recent studies have identified potential drug targets and biomarkers associated with ANAPC5, including the protein p16INK4a and the protein PDCD1. Further research is needed to fully understand the role of ANAPC5 in DNA replication and its potential as a drug target and biomarker.

Protein Name: Anaphase Promoting Complex Subunit 5

Functions: Component of the anaphase promoting complex/cyclosome (APC/C), a cell cycle-regulated E3 ubiquitin ligase that controls progression through mitosis and the G1 phase of the cell cycle. The APC/C complex acts by mediating ubiquitination and subsequent degradation of target proteins: it mainly mediates the formation of 'Lys-11'-linked polyubiquitin chains and, to a lower extent, the formation of 'Lys-48'- and 'Lys-63'-linked polyubiquitin chains

The "ANAPC5 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ANAPC5 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets